China National Pharmaceutical Group Corp (Sinopharm) has scheduled its IPO with plans to raise 7 billion RMB ($1.03 billion). The company will list on the Hong Kong exchange as H-shares in October, according to the Wen Wei Po newspaper. The company is one of the largest distributors of pharmaceutical products in China, and it also develops and produces its own pharmaceuticals. More details...